Lack of Evidence for Germline Pathogenic Variants in Gastrointestinal Polyposis and Other Phenotypes Suggestive of PTEN-hamartoma-tumor Syndrome
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lee Y, Chen M, Lee J, Zhang J, Lin S, Fu T
. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019; 364(6441).
PMC: 7081834.
DOI: 10.1126/science.aau0159.
View
2.
Lee Y, Yehia L, Kishikawa T, Ni Y, Leach B, Zhang J
. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition. N Engl J Med. 2020; 382(22):2103-2116.
PMC: 7839065.
DOI: 10.1056/NEJMoa1914919.
View
3.
Jiang H, Dempsey D, Cole P
. Ubiquitin Ligase Activities of WWP1 Germline Variants K740N and N745S. Biochemistry. 2021; 60(5):357-364.
PMC: 8262107.
DOI: 10.1021/acs.biochem.0c00869.
View
4.
Novelli G, Novelli A, Borgiani P, Cocciadiferro D, Biancolella M, Agolini E
. WWP1 germline variants are associated with normocephalic autism spectrum disorder. Cell Death Dis. 2020; 11(7):529.
PMC: 7376150.
DOI: 10.1038/s41419-020-2681-z.
View
5.
Condello V, Nikitski A, Foulkes W, Nikiforov Y
. Prevalence of Gene Mutations in Patients with Thyroid Nodules. Thyroid. 2020; 31(7):1147-1148.
DOI: 10.1089/thy.2020.0919.
View